Shandong Shanda Wit Science and Technology Co Ltd (SHE:000915) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Shanda Wit Science and Technology Co Ltd (000915)
Shandong Shanda Wit Science and Technology Co Ltd (SHE:000915) has a market capitalization of $823.99 Million (CN¥5.63 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #9862 globally and #2570 in its home market, demonstrating a -4.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Shanda Wit Science and Technology Co Ltd's stock price CN¥24.03 by its total outstanding shares 234331485 (234.33 Million). Also see total assets of Shandong Shanda Wit Science and Technolo for a full breakdown of the balance sheet.
Shandong Shanda Wit Science and Technology Co Ltd Market Cap History: 2015 to 2026
Shandong Shanda Wit Science and Technology Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $776.07 Million to $823.99 Million (-0.52% CAGR). Also see Shandong Shanda Wit Science and Technolo (000915) cash conversion ratio for how efficiently the company converts equity into cash flow.
Shandong Shanda Wit Science and Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Shanda Wit Science and Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Shandong Shanda Wit Science and Technolo for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.45x
Shandong Shanda Wit Science and Technology Co Ltd's market cap is 0.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.87x
Shandong Shanda Wit Science and Technology Co Ltd's market cap is 1.87 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $776.07 Million | $1.23 Billion | $152.46 Million | 0.63x | 5.09x |
| 2016 | $932.50 Million | $1.54 Billion | $198.39 Million | 0.60x | 4.70x |
| 2017 | $869.94 Million | $1.77 Billion | $243.20 Million | 0.49x | 3.58x |
| 2018 | $433.00 Million | $1.53 Billion | $129.69 Million | 0.28x | 3.34x |
| 2019 | $787.15 Million | $1.80 Billion | $204.10 Million | 0.44x | 3.86x |
| 2020 | $701.14 Million | $1.82 Billion | $290.76 Million | 0.39x | 2.41x |
| 2021 | $923.88 Million | $2.03 Billion | $380.26 Million | 0.46x | 2.43x |
| 2022 | $1.42 Billion | $2.34 Billion | $526.86 Million | 0.60x | 2.69x |
| 2023 | $921.12 Million | $2.48 Billion | $585.26 Million | 0.37x | 1.57x |
| 2024 | $966.29 Million | $2.13 Billion | $515.59 Million | 0.45x | 1.87x |
Competitor Companies of 000915 by Market Capitalization
Companies near Shandong Shanda Wit Science and Technology Co Ltd in the global market cap rankings as of September 19, 2026. Review how tangible is Shandong Shanda Wit Science and Technolo's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Shandong Shanda Wit Science and Technology Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Shandong Shanda Wit Science and Technology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Shanda Wit Science and Technology Co Ltd's market cap moved from $776.07 Million to $ 823.99 Million, with a yearly change of -0.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥823.99 Million | -27.27% |
| 2025 | CN¥1.13 Billion | +17.25% |
| 2024 | CN¥966.29 Million | +4.90% |
| 2023 | CN¥921.12 Million | -34.96% |
| 2022 | CN¥1.42 Billion | +53.29% |
| 2021 | CN¥923.88 Million | +31.77% |
| 2020 | CN¥701.14 Million | -10.93% |
| 2019 | CN¥787.15 Million | +81.79% |
| 2018 | CN¥433.00 Million | -50.23% |
| 2017 | CN¥869.94 Million | -6.71% |
| 2016 | CN¥932.50 Million | +20.16% |
| 2015 | CN¥776.07 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Shandong Shanda Wit Science and Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $823.99 Million USD |
| MoneyControl | $823.99 Million USD |
| MarketWatch | $823.99 Million USD |
| marketcap.company | $823.99 Million USD |
| Reuters | $823.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more